Last updated: July 26, 2023
Sponsor: Gangnam Severance Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Tuohy needle group
Quincke needle group
Clinical Study ID
NCT05925439
3-2023-0145
Ages > 19 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient diagnosed with S1 radiculopathy because S1 root compression was confirmedon MRI and related symptoms 2. NRS of back and/or radiating pain score of 4 or more 3.Patients aged 19 years or older
Exclusion
Exclusion Criteria:
- Cases in which lumbar count is expected to be difficult due to lumbarization,sacralization, or lumbosacral transition 2. When the S1 posterior foramen is notclearly identified on ultrasound 3. Malignancy 4. Systemic infections 5. Bleedingtendency 6. Contrast allergy 7. Pregnant Women 8. If you cannot read or agree to theconsent form 9. If you are unable to sign the consent form yourself
Study Design
Total Participants: 284
Treatment Group(s): 2
Primary Treatment: Tuohy needle group
Phase:
Study Start date:
June 30, 2023
Estimated Completion Date:
June 22, 2025
Connect with a study center
GangnamSeverance Hospital
Seoul,
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.